BGIGBahl & Gaynor Income Growth ETF
Seeks current and growing dividend income, downside protection, and long-term capital appreciation.
By Bahl & Gaynor Investment Counsel · Launched 2023
Annual Cost
0.45%
#2,223 of 5,562 · average
Fund Size
$2.1B
#725 of 5,562 · large
Return (1Y)Goal
+20.6%
Track Record
2 years
#3,158 of 5,562 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,085+20.9%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 41.1% of fundmoderately concentrated
Eli Lilly & Co
5.7%
Johnson & Johnson
5.3%
Broadcom Inc
5.1%
AbbVie Inc
4.7%
Microsoft Corp
4.6%
Travelers Cos Inc/The
3.6%
JPMorgan Chase & Co
3.3%
Williams Cos Inc/The
3.0%
Procter & Gamble Co/The
3.0%
NextEra Energy Inc
2.8%
Asset allocation
Stocks
99.9%
Cash
0.2%
By sector
Technology
25.7%
Healthcare
15.2%
Financial Services
14.4%
Industrials
10.3%
Energy
10.2%
Utilities
7.2%
Consumer Defensive
6.8%
Consumer Cyclical
4.8%
Other
5.3%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
9.0%Low
Year-on-year price swings
Max drawdown
-13.2%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks current and growing dividend income, downside protection, and long-term capital appreciation.
- Strategy
- Actively managed, invests primarily in large-cap U.S. dividend-paying equities. Focuses on companies with strong fundamentals, targeting those with high-quality business models and reasonable valuations.
- Inception date
- September 14, 2023
- Fund family
- Bahl & Gaynor Investment Counsel
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed BGIG. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19